Enhanced recovery after surgery in colorectal cancer. Instituto Nacional de Enfermedades Neoplásicas

• Autores: Guevara Jabiles, Andrés, Cedeño Ascoy, Edith Elizabeth, Berrospi Espinoza, Francisco Manuel, Aguilar Onofre, Elena, Chávez Passiuri, Iván, Luque-Vásquez Vásquez, Carlos, Olivos Gonzáles, Juan Francisco, Mantilla Quispe, Raúl, Ruiz Figueroa, Eloy, Payet Meza, Eduardo
• Formato: artículo
• Fecha de Publicación: 2021
• Institución: Colegio Médico del Perú
• Repositorio: Acta Médica Peruana
• Lenguaje: español
• OAI Identifier: oai:amp.cmp.org.pe:article/1922
• Enlace del recurso: https://amp.cmp.org.pe/index.php/AMP/article/view/1922
• Nivel de acceso: acceso abierto
• Materia: Cirugía Colorrectal; Cáncer Colorrectal; Recuperación Mejorada Después De Cirugía; Perú; Colorectal Surgery; Colorectal Cancer; Enhanced Recovery After Surgery

Aim: Describe and analyze the safety of the “Enhanced Recovery After Surgery” (ERAS) protocol in elective procedures for colorectal cancer. Materials and Methods: Observational study of 272 patients with colorectal cancer who underwent elective surgery from January 2019 to September 2020 at the “Instituto Nacional de Enfermedades Neoplásicas”, Peru, were retrospectively collected. U Mann-Whitney test, Pearson chi-square test and odds ratios (OR) were used for statistical analysis. Results: 90 patients were included in the ERAS program with a median postoperative hospital stay of 3 days (range 3-19). Laparoscopic surgery was performed in 53% of the patients with significantly shorter postoperative hospital stay in comparison with the patients who had open surgery (p=0,035). Oral food intake less than 24 hours postoperatively was 91%, and early mobilization in 89% of the cases. The postoperative complication rate was 29%, higher in rectal/anus resection than in colonic resections (40% vs 20%, p=0,043) (OR=2,67, CI 95%: 1,02 – 7,01). Eight patients had a major postoperative complication, four with anastomotic leakage and four required hospital readmission. Conclusions: The perioperative management of ERAS program for colorectal cancer in elective surgery is safe and feasible with acceptable morbimortality risk.